Govt, pvt sector need to work in tandem for increasing healthcare affordability: Experts

Image
Press Trust of India New Delhi
Last Updated : Feb 12 2019 | 4:30 PM IST

The government and private players need to work together in healthcare sector to increase affordability of medical services as rising cost impacts access to patients, experts said Tuesday.

Arun Mitra, core committee member of the Alliance of Doctors for Ethical Healthcare, suggests that the government should take steps such as 'one drug, one price' formula, strengthening of National Pharmaceutical Pricing Authority (NPPA) and public sector units in pharma sector.

These steps would help increase access to affordable medicines to all people, he said at a roundtable meeting on 'Cost of Life Saving Medicines - Is there a way out?', organised by startup Straight Drive.

Mitra also emphasised on the need to boost expenditure on R&D by the government on medicines.

Priti Nanda Sibal, Founder, AB Hospitals and Mediskool Health Services, said the government should involve all the stakeholders while taking decisions on price regulations for medicines.

"Multiple pillars are involved in this segment and they have to come together to promote the growth of the sector," she said.

Pratibha Sivasubramaniam, a lawyer who works in the sector, said healthcare is a basic right of the people and the government should ensure that.

"Steps should be taken to reduce cost of medicines and increase afffordability in the healthcare sector," she said adding the private sector should be transparent in telling the cost of cure to patients.

Healthcare equipment maker Vygon India MD Pavan Choudary said there is a need to focus on areas like transparency and alternative mechanism of price capping.

Mukund Trivedy, Founder of Straight Drive said the government must increase spending on the healthcare sector and promoting research and development of medicines.

"On the other hand, the private healthcare sector would have to be transparent in their pricing. Licensing and approval of drugs through the regulator should be made more stringent based on scientific data ," he said.

He added that there is an urgent need for the government to focus on improving primary healthcare centres in the country.

Disclaimer: No Business Standard Journalist was involved in creation of this content

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Feb 12 2019 | 4:30 PM IST

Next Story